Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enanta Pharmaceuticals (ENTA) Change in Accured Expenses (2016 - 2025)

Enanta Pharmaceuticals filings provide 14 years of Change in Accured Expenses readings, the most recent being -$5.2 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 77.87% to -$5.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$2.2 million, a 21.32% decrease, with the full-year FY2025 number at $58000.0, up 101.03% from a year prior.
  • Change in Accured Expenses hit -$5.2 million in Q4 2025 for Enanta Pharmaceuticals, down from $2.4 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $4.7 million in Q3 2021 to a low of -$6.7 million in Q4 2023.
  • Median Change in Accured Expenses over the past 5 years was $669500.0 (2023), compared with a mean of -$197550.0.
  • Biggest five-year swings in Change in Accured Expenses: surged 939.85% in 2021 and later plummeted 277.88% in 2024.
  • Enanta Pharmaceuticals' Change in Accured Expenses stood at $4.2 million in 2021, then crashed by 256.89% to -$6.6 million in 2022, then fell by 2.08% to -$6.7 million in 2023, then surged by 56.8% to -$2.9 million in 2024, then crashed by 77.87% to -$5.2 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$5.2 million (Q4 2025), $2.4 million (Q3 2025), and $2.5 million (Q2 2025) per Business Quant data.